Organic revenue growth of 14-15% over next 3 years
Driven by 8-9% patient volume growth and ~5% realization improvement, with potential price increases.
METROPOLISHEALTHCARE / guidance tracker
Keep management guidance in view.
Metropolis Healthcare · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Group EBITDA margin target of 27-28% over next 3 years
Supported by operating leverage, productivity gains, and core diagnostics reaching 20%+ margin.
125-150 bps margin improvement in FY27
Management expects EBITDA margin expansion of 125-150 bps in the coming fiscal year.
Add 1500 collection centers and 100 mini hubs over 3 years
Expand asset-light network and upgrade centers to include basic radiology, targeting center-to-lab ratio of 35:1.